Related Experiment Videos

Modulation of fibrin assembly and polymerization by the beta-amyloid of Alzheimer's disease

D L Merkle1, C H Cheng, F J Castellino

  • 1Department of Chemistry and Biochemistry, University of Notre Dame, IN 46556, USA.

Insights

Amyloid beta protein (A beta P) significantly alters fibrin (Fn) clot formation. This interaction, observed in Alzheimer's disease (AD) models, impacts blood clotting and may contribute to intracerebral hemorrhages.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Hematology

Background:

  • Vascular amyloid beta protein (A beta P) deposition is linked to recurrent intracerebral hemorrhages.
  • Alzheimer's disease (AD) involves A beta P pathology.

Purpose of the Study:

  • To investigate the effect of A beta P on fibrin (Fn) formation and fibrinolysis.
  • To understand how AD-related amyloid peptides influence blood clot structure.

Main Methods:

  • Electron microscopy and light scattering studies were used to analyze Fn clots.
  • Kinetic assays with fibrinogen (Fg), plasminogen, tissue-type plasminogen activator, and thrombin were performed.
  • Turbidometric analysis assessed Fn clot density in the presence of A beta P.

Main Results:

  • A beta P formed networks with amyloid fibers, showing decreased lateral Fn-Fn interactions.
  • Thrombin-treated Fg formed denser, more compact Fn fibers with increasing A beta P concentrations.
  • Alterations in mass-to-length ratios, fiber radii, and densities indicated a modified Fn matrix.

Conclusions:

  • Amyloid-forming peptides and proteins in AD significantly alter the structure of fibrin clots.
  • These alterations in Fn matrix formation may have implications for understanding A beta P-associated pathologies like intracerebral hemorrhage.

Related Concept Videos